Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702621 · ClinicalTrials.gov registry record · Phase 3
Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery
A Phase 3 study of Colorectal Surgery, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03702621: Completed Phase 3 study of Colorectal Surgery, sponsored by Indiana University.
NCT03702621 is a Phase 3 study of Colorectal Surgery that has completed, run by Indiana University. The registered enrollment target is 90 participants, below the 319-participant average among 8 other Colorectal Surgery trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03702621, a Phase 3 study of Colorectal Surgery, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a colorectal surgery
Primary Outcome
The VAS score at rest will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 1-10 for documentation with 10 being the worst pain and 0 being no pain
Conditions Studied
Interventions
- DRUG Bupivacaine Hydrochloride
- DRUG liposomal Bupivacaine
Study Locations (1)
Indiana
- Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-08-30 |
| Est. Completion | 2020-03-13 |
| Phase | Phase 3 |
What the finished NCT03702621 record still lists
NCT03702621 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 319-participant average among 8 other Colorectal Surgery trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Colorectal Surgery appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine Hydrochloride is the first listed.
NCT03702621 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03702621 about?
NCT03702621 is a clinical study titled "Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery". The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a colorectal surgery
What is the current status of trial NCT03702621?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2018-08-30. Estimated completion is 2020-03-13.
What conditions does trial NCT03702621 study?
This clinical trial studies the following conditions: Colorectal Surgery.
What interventions are being tested in trial NCT03702621?
The interventions under investigation include: Bupivacaine Hydrochloride (DRUG), liposomal Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03702621?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03702621 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03702621's enrollment target sits among peer trials
90 8th of 8 higher than 1 of 8 other Colorectal Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
RECRUITING · NA
-
Duration of Urinary Catheterization
RECRUITING · NA
-
A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection
RECRUITING · NA
-
COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study
COMPLETED · Phase 4
-
Application to Improve Patient Engagement and Decrease Postoperative Opioid Consumption in Patients for Colorectal Surgery
COMPLETED
-
Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Improvement Project
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI